ADIL Adial Pharmaceuticals Inc
7,353
$1.45
$0.00
(0.00%)
| Watchers | 7,353 |
| 52-Wk Low | $0.765 |
| 52-Wk High | $14.00 |
| Market Cap | $6.14M |
| Volume | 100.00 |
| 52-Wk High | $14.00 |
| 52-Wk Low | $0.765 |
Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars TodayBenzinga • about 2 months ago
On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones Industrial Average fell by 1.1% to 38,461.51, the S&P 500 dropped nearly 1% to 5,160.64, and the Nasdaq ended the day down by 0.8...
Share to Feed
Acciones al alza
Jaguar Health (NASDAQ:JAGX) avanzaron un 43,99% para establecerse en los 0,13 d lares durante la sesi n del pre-market del mi rcoles.
Adial Pharmaceuticals (NASDAQ:ADIL) ganaron un...
Received Favorable Feedback from US and EU Regulatory Agencies Advancing Discussions with Potential Strategic Partners Received $4.3 Million in Gross Proceeds from Warrant Exercises Subsequent to...
Adial Pharmaceuticals reports FY results...
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest...
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL Free Report) Equities researchers at Litchfield Hills Research issued their Q1 2025 EPS estimates for Adial Pharmaceuticals in a research note...
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL Free Report) Litchfield Hills Research issued their Q1 2025 earnings estimates for shares of Adial Pharmaceuticals in a report released on...
CHARLOTTESVILLE, Va., March 01, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ( Adial or the Company ), a clinical-stage biopharmaceutical company focused on developing...
Gagnants
L'action BioVie (NASDAQ:BIVI) a mont vendredi de 54,95% 1,92 dollars lors de la session ordinaire.
Le titre Adial Pharmaceuticals (NASDAQ:ADIL) a mont de 51,96% 3,10 dollars.
L'action...